75%Confidence
0Views
FDASource
2026-03-18Date
Summary
Kirkman's topical anesthetic spray recall due to unsupported expiry dates reveals inadequate stability testing practices that undermine product efficacy claims. This could trigger increased FDA scrutiny on expiry dating practices for topical pharmaceuticals and damage consumer trust in the Kirkman brand's quality assurance.
Actionable: Review stability documentation for all topical pharmaceutical products and verify expiry date validation from suppliers.
AI Confidence: 75%
Data Points
firmHTO Nevada Inc. dba Kirkman
classificationClass II
statusOngoing
distributionNationwide within the U.S
productFIVE-STAR, VASOCAINE Spray, (Lidocaine HCl 4%, Racepinephrine HCl 0.01%), 4oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-01
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now